Tularemia

Organism/Infectivity

Francisella tularensis — small GNB coccobacillus. REMARKABLY LOW INFECTIOUS DOSE (10-50 organisms via inhalation) — recognized potential BIOTHREAT AGENT (select agent), high-yield distinctive fact.

Transmission — diverse routes (testable set)

• Direct contact infected animal tissue: RABBITS/HARES classic reservoir — hunters/trappers/carcass handlers = occupational risk
• Arthropod bite: ticks, deer flies
• Ingestion: contaminated water, undercooked infected meat
• Inhalation: contaminated aerosols/dust (e.g. mowing over carcasses) — MOST biothreat-concerning route given low infectious dose + severe pneumonic disease

Clinical — ROUTE-DETERMINES-PRESENTATION (key organizing point)

Ulceroglandular (most common): skin inoculation (animal contact/tick bite) → SKIN ULCER at site + painful regional lymphadenopathy. COMPARE/CONTRAST vs plague bubo: both = painful regional LN from peripheral inoculation, but tularemia’s SKIN ULCER distinguishes it (plague bubonic form typically lacks ulcer). Oculoglandular: conjunctival inoculation → conjunctivitis + preauricular lymphadenopathy. Oropharyngeal: ingestion → pharyngitis/tonsillitis + cervical lymphadenopathy. Pneumonic: inhalation (or hematogenous spread) → pneumonia. MOST SEVERE form, highest mortality, greatest biothreat/aerosol concern. Typhoidal: systemic, NO localizing ulcer/lymphadenopathy — fever + toxicity only, diagnostic difficulty (lacks classic clues).

Diagnosis

Culture: HAZARDOUS TO LAB PERSONNEL (low infectious dose, documented lab-acquired infections) — MUST NOTIFY LAB of suspected tularemia for enhanced biosafety handling, not routine bench processing. Serology (rising Ab titer): often preferred safer primary approach. PCR: supplemental.

Treatment

Streptomycin or gentamicin = 1st-line (same aminoglycoside approach as plague — shared susceptibility pattern). Doxycycline or ciprofloxacin = alternatives, esp. milder presentations. Generally good response with prompt Tx; pneumonic form severity underscores need for early recognition per route-dependent pattern above.

The Organism and Its Genuinely Distinctive Infectivity

Francisella tularensis, a small gram-negative coccobacillus, causes tularemia — genuinely, specifically notable among the organisms covered in this curriculum for its remarkably low infectious dose, with as few as 10-50 organisms sufficient to cause disease via certain exposure routes (particularly inhalation), a real, specifically testable point that has made F. tularensis a recognized potential biological threat agent given how efficiently a small quantity of organism could theoretically cause widespread disease — genuinely worth remembering both as a clinical microbiology fact and as context for why this organism appears on biodefense/select-agent lists alongside a small number of other organisms sharing similarly high infectivity-to-dose ratios.

Transmission — A Genuinely Diverse Range of Routes

Tularemia is transmitted through a genuinely unusually broad range of distinct routes, and this route diversity is itself a specifically testable point worth understanding as a coherent set rather than memorizing individually: direct contact with infected animal tissues (classically rabbits and hares, the most frequently cited reservoir animals, though a wide range of other wild mammals can also harbour the organism) — a genuinely important, specifically testable point of occupational/exposure association with hunters, trappers, and individuals handling wild animal carcasses; arthropod vector bites (ticks and, to a lesser extent, deer flies); ingestion of contaminated water or undercooked infected meat; and inhalation of contaminated aerosols or dust (notably associated with agricultural activities like mowing over contaminated animal carcasses, and this specific inhalational route being the one most concerning from a biothreat perspective, given the low infectious dose noted above and the severity of the resulting pneumonic disease form).

Clinical Manifestations — Route-Dependent Presentation

Tularemia’s clinical presentation is genuinely, specifically determined by the route of inoculation, a real, high-yield organizing point for this topic’s clinical section: ulceroglandular tularemia, the most common overall presentation, follows skin inoculation (animal contact or tick bite) and produces a skin ulcer at the inoculation site together with painful regional lymphadenopathy — a presentation genuinely, specifically worth comparing and contrasting with plague’s bubo, since both produce painful regional lymphadenopathy from a peripheral inoculation site, though tularemia’s accompanying skin ulcer is a distinguishing feature plague’s bubonic form typically lacks. Oculoglandular tularemia follows inoculation via the conjunctiva (e.g., touching the eye with contaminated hands), producing conjunctivitis with regional (preauricular) lymphadenopathy. Oropharyngeal tularemia follows ingestion, causing pharyngitis/tonsillitis with cervical lymphadenopathy. Pneumonic tularemia, from inhalation (or, less commonly, haematogenous spread from another form), causes pneumonia and is genuinely the most severe presentation, carrying the highest mortality among the tularemia clinical forms and being the presentation of greatest specific biothreat/aerosol-exposure concern. Typhoidal tularemia, a genuinely less common systemic form without an obvious localizing ulcer or lymphadenopathy, presents instead with fever and systemic toxicity, sometimes creating real diagnostic difficulty given the absence of the more classic, localizing clinical clues seen in the other forms.

Diagnosis

Direct culture of F. tularensis is genuinely, specifically notable as hazardous to laboratory personnel given the organism’s low infectious dose and documented history of laboratory-acquired infections — this is a real, practically important point, meaning clinical suspicion of tularemia should specifically be communicated to the laboratory so that appropriate biosafety precautions (handling under enhanced containment) are used rather than routine open-bench processing. Serology (demonstrating a rising antibody titre) is therefore often the preferred, safer primary diagnostic approach in practice, supplemented by PCR where available.

Treatment

Streptomycin or gentamicin are first-line treatment (the same aminoglycoside-based approach as plague, reflecting general antimicrobial susceptibility patterns shared by these two organisms), with doxycycline or ciprofloxacin as alternative options, particularly for milder presentations — treatment response is generally good when initiated appropriately, though the pneumonic form’s severity underscores the importance of prompt recognition and treatment given the route-dependent presentation and severity pattern established above.